Guardant Health
GH
#1586
Rank
โ‚น1.193 T
Marketcap
โ‚น9,190
Share price
-0.12%
Change (1 day)
243.00%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): -โ‚น277.33

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -โ‚น288.15. In 2024 the company made an earnings per share (EPS) of -โ‚น319.57 an increase over its 2023 EPS that were of -โ‚น384.20.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น277.33-13.22%
2024-โ‚น319.57-16.82%
2023-โ‚น384.20-33.13%
2022-โ‚น574.5160%
2021-โ‚น359.0755.04%
2020-โ‚น231.60207.14%
2019-โ‚น75.40-19.81%
2018-โ‚น94.03

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Natera
NTRA
-โ‚น192.10-33.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
-โ‚น431.52 49.75%๐Ÿ‡บ๐Ÿ‡ธ USA